Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Feb 11, 2013  |  BioCentury | Emerging Company Profile

GeneCentric: Cancer sign-off

to an anti-angiogenesis drug, she said. The gene signature, also licensed from UNC, includes VEGF, angiopoietin-like 4
ANGPTL4) , adrenomedullin (ADM; AM) and solute carrier family 16 member 3 (SLC16A3) . Perou was …
12:00 AM, Dec 03, 2012  |  BioCentury | Emerging Company Profile

Lipigon: LPL protectorate

activity to about 60,000 ester bonds per minute. By contrast, in disease states, inhibitors including angiopoietin-like 4
ANGPTL4) and apolipoprotein C-III ( APOCIII ; APOC3 ) become overly active and cleave LPL into …